Connection

Walter Ageno to Atrial Fibrillation

Back to Details
This is a "connection" page, showing publications Walter Ageno has written about Atrial Fibrillation.
Walter Ageno
Connection Strength
1.291
Atrial Fibrillation
  1. Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study. Thromb Res. 2021 07; 203:138-141.
    View in: PubMed
    Score: 0.317
  2. The management of anticoagulant treatment in non-valvular atrial fibrillation real-world patients. Eur J Intern Med. 2019 04; 62:7-8.
    View in: PubMed
    Score: 0.273
  3. Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation. Expert Opin Pharmacother. 2017 Sep; 18(13):1325-1332.
    View in: PubMed
    Score: 0.244
  4. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)? Semin Thromb Hemost. 2021 06; 47(4):338-340.
    View in: PubMed
    Score: 0.075
  5. Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants? Intern Emerg Med. 2018 10; 13(7):1001-1004.
    View in: PubMed
    Score: 0.064
  6. Clinical conundrums in antithrombotic therapy management: A Delphi Consensus panel. Int J Cardiol. 2017 Dec 15; 249:249-256.
    View in: PubMed
    Score: 0.061
  7. [The slow acceptance of new oral anticoagulants in Italy: a critical analysis of a problem]. G Ital Cardiol (Rome). 2017 Mar; 18(3):208-218.
    View in: PubMed
    Score: 0.059
  8. Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide. Adv Ther. 2017 03; 34(3):620-637.
    View in: PubMed
    Score: 0.059
  9. Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. Drug Saf. 2016 12; 39(12):1175-1187.
    View in: PubMed
    Score: 0.058
  10. The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. Thromb Haemost. 2019 Jan; 119(1):14-38.
    View in: PubMed
    Score: 0.017
  11. Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism. Int J Cardiol. 2018 Oct 15; 269:75-79.
    View in: PubMed
    Score: 0.016
  12. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry. Intern Emerg Med. 2018 Oct; 13(7):1051-1058.
    View in: PubMed
    Score: 0.016
  13. Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? Intern Emerg Med. 2017 Oct; 12(7):923-934.
    View in: PubMed
    Score: 0.015
  14. Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med. 2017 Apr; 12(3):387-406.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.